Advertisement
ISRG vs SYK
Which Stock Would AI Choose? Intuitive Surgical (ISRG) vs. Stryker (SYK) Stock Comparison
Key Takeaways
- Intuitive Surgical (ISRG) focuses on robotic-assisted surgery with the da Vinci platform, delivering high-margin recurring revenue from procedures, while Stryker (SYK) offers a diversified portfolio spanning orthopedics, MedSurg, and neurotechnology with growing robotics exposure via Mako.
- Both stocks have faced pressure in recent market activity, with ISRG showing a steeper year-to-date decline amid concerns over U.S. procedure growth and SYK impacted by manufacturing disruptions in its vascular segment.
- ISRG reported strong Q2 results with revenue growth near 19% year-over-year and a positive meta-analysis highlighting improved patient outcomes across multiple procedures, supporting long-term adoption potential.
- SYK has launched new foot and ankle innovations and maintains guidance for mid-single-digit organic revenue growth, though operational challenges have weighed on near-term sentiment.
- Relative positioning shows ISRG trading at a premium valuation with higher beta reflecting greater volatility, while SYK offers broader sector exposure and a lower beta profile.
- Market sentiment for both remains tied to healthcare capital spending trends and procedure volumes in a post-pandemic environment.
Introduction
Intuitive Surgical (ISRG) and Stryker (SYK) represent two prominent players in the medical technology sector, each with distinct approaches to surgical innovation and healthcare solutions. ISRG specializes in minimally invasive robotic systems, while SYK provides a broad range of orthopedic, surgical, and neurovascular products. This comparison appeals to investors and traders seeking exposure to medtech growth drivers, including procedure volumes, product adoption, and operational resilience. Those focused on relative performance, sector positioning, and risk-adjusted profiles within healthcare equipment may find the analysis particularly relevant for portfolio construction and market timing decisions.
ISRG Overview and Recent Performance
Intuitive Surgical (ISRG) develops and markets the da Vinci surgical system for robotic-assisted minimally invasive procedures. The company generates substantial recurring revenue through instruments and accessories tied to procedure volumes. In recent market activity, shares have declined amid a broader pullback in high-valuation growth names, with year-to-date performance reflecting concerns over decelerating U.S. procedure growth following earlier post-pandemic strength. Recent positive developments include a large-scale study demonstrating improved patient outcomes, shorter hospital stays, and reduced complications compared with traditional approaches across 13 conditions. Analyst sentiment has shown some moderation, including a recent downgrade to Hold by one firm, though the consensus remains moderately bullish with price targets well above current levels. Broader influences include hospital capital expenditure trends and international expansion.
SYK Overview and Recent Performance
Stryker (SYK) operates as a diversified medical technology company with leading positions in orthopedics, MedSurg equipment, and neurotechnology. Its portfolio includes robotic-assisted solutions such as the Mako system for joint replacements. In recent market activity, the stock has experienced downward pressure linked to manufacturing issues in the peripheral vascular business and lingering effects from earlier operational disruptions. Despite these headwinds, the company has advanced new product launches in foot and ankle care and maintains full-year guidance for organic revenue growth in the mid-to-high single digits. Sentiment has been further shaped by ongoing supply chain normalization and hospital procedure trends. SYK's lower beta relative to the broader market has provided some defensive characteristics amid volatility.
Trending AI Robots
Tickeron offers a curated selection of AI trading bots through its Trending AI Robots page. The platform features hundreds of AI Trading Bots that trade thousands of different tickers, yet only the strongest performers suited to prevailing market conditions earn placement in this trending section. Available bots exhibit varied annualized returns often ranging from 60% to over 200% in documented periods, with win rates commonly between 55% and 70% and profit factors frequently exceeding 2.0. Strategies differ widely in timeframes, from 5-minute scalping to longer swing approaches, risk parameters, and ticker focus. All AI trading bots maintain distinct trading styles, performance statistics, and sets of tickers. Review the full range of options on the Trending AI Robots page to explore those aligned with current conditions.
Head-to-Head Comparison
Intuitive Surgical (ISRG) operates a focused robotic surgery model centered on the da Vinci ecosystem, creating a high-margin recurring revenue stream from procedure volume. In contrast, Stryker (SYK) delivers diversified exposure across multiple medtech categories, reducing reliance on any single technology or procedure type. Growth drivers for ISRG hinge on da Vinci 5 adoption and expanding clinical evidence, while SYK benefits from orthopedic leadership, Mako robotics, and recent vascular and foot-and-ankle innovations. Recent momentum has favored neither decisively, with both stocks underperforming broader indices amid sector-specific pressures. Risk factors differ: ISRG faces higher valuation multiples and sensitivity to capital spending cycles, whereas SYK contends with manufacturing execution and integration of acquisitions. Sector exposure for ISRG is concentrated in robotic surgery, while SYK spans orthopedics and hospital products, offering different cyclical sensitivities. Market sentiment reflects these trade-offs, with ISRG viewed through a growth lens and SYK through a stability and recovery perspective.
Tickeron AI Verdict
Based on observable factors such as trend consistency, stability metrics, and relative positioning in recent market activity, Tickeron’s AI models would currently assign a probabilistic edge to Intuitive Surgical (ISRG). The company’s procedure-driven recurring revenue and positive clinical data provide clearer momentum signals compared with Stryker (SYK)’s ongoing operational adjustments. However, SYK’s diversified base and lower volatility profile could support outperformance in certain risk environments. The assessment remains probabilistic and subject to evolving fundamentals and market conditions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Disclaimers and LimitationsTo compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISRG is a Buy and SYK is a Buy.
ISRG | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 40 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 85 | 92 | |
SMR RATING 1..100 | 51 | 53 | |
PRICE GROWTH RATING 1..100 | 53 | 65 | |
P/E GROWTH RATING 1..100 | 72 | 87 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SYK's Valuation (7) in the Medical Specialties industry is significantly better than the same rating for ISRG (76). This means that SYK’s stock grew significantly faster than ISRG’s over the last 12 months.
ISRG's Profit vs Risk Rating (85) in the Medical Specialties industry is in the same range as SYK (92). This means that ISRG’s stock grew similarly to SYK’s over the last 12 months.
ISRG's SMR Rating (51) in the Medical Specialties industry is in the same range as SYK (53). This means that ISRG’s stock grew similarly to SYK’s over the last 12 months.
ISRG's Price Growth Rating (53) in the Medical Specialties industry is in the same range as SYK (65). This means that ISRG’s stock grew similarly to SYK’s over the last 12 months.
ISRG's P/E Growth Rating (72) in the Medical Specialties industry is in the same range as SYK (87). This means that ISRG’s stock grew similarly to SYK’s over the last 12 months.
| ISRG | SYK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 37% | 1 day ago 76% |
| Stochastic ODDS (%) | 1 day ago 68% | N/A |
| Momentum ODDS (%) | 1 day ago 68% | 5 days ago 53% |
| MACD ODDS (%) | 1 day ago 47% | N/A |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 52% |
| TrendMonth ODDS (%) | 1 day ago 64% | 1 day ago 53% |
| Advances ODDS (%) | 1 day ago 67% | 13 days ago 56% |
| Declines ODDS (%) | 19 days ago 60% | 3 days ago 51% |
| BollingerBands ODDS (%) | 1 day ago 44% | 1 day ago 80% |
| Aroon ODDS (%) | 1 day ago 68% | 1 day ago 49% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ISRG’s FA Score shows that 0 FA rating(s) are green while SYK’s FA Score has 1 green FA rating(s).
- ISRG’s FA Score: 0 green, 5 red.
- SYK’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ISRG’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 3 bullish TA indicator(s).
- ISRG’s TA Score: 5 bullish, 5 bearish.
- SYK’s TA Score: 3 bullish, 5 bearish.
Price Growth
ISRG (@Pharmaceuticals: Other) experienced а +3.01% price change this week, while SYK (@Medical/Nursing Services) price change was -1.00% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.16%. For the same industry, the average monthly price growth was -3.39%, and the average quarterly price growth was +19.68%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.06%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was +1.93%.
Reported Earning Dates
ISRG is expected to report earnings on Oct 20, 2026.
SYK is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+1.16% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-2.06% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ISRG and
Correlation & Price change
A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To ISRG | 1D Price Change % | ||
|---|---|---|---|---|
| ISRG | 100% | +1.42% | ||
| BSX - ISRG | 73% Closely correlated | -1.70% | ||
| SYK - ISRG | 64% Loosely correlated | +0.97% | ||
| NTRA - ISRG | 54% Loosely correlated | +0.92% | ||
| GKOS - ISRG | 51% Loosely correlated | -0.29% | ||
| PODD - ISRG | 49% Loosely correlated | +0.26% | ||
More | ||||
SYK and
Correlation & Price change
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.